baber/WOPTO huggingface dataset:
Patent CA-2669419-A1 (CA)
Title: Shaving razor with additional trimming blade
Inventor: PROVOST CRAIG
IPC: B26B21/40
Filed: 2005-03-07
Abstract: A shaving razor (10) including a housing (20) having a primary guard (22) at a front of the housing and a primary cap (24) at an upper surface at a back of the housing, one or more primary shaving blades (28) between the primary guard and said primary cap, and a trimming blade (504) mounted at the back of the housing having a trimming blade cutting edge (536) oriented away from the upper surface. The razor also has an elongated handle (14) having a curve (720) at end secured to the housing, with the curve being concave on the same side as the primary blades. The elongated handle can also have a finger pad (726) at the end of the handle secured to the housing on the same side as the primary blades. The elongated handle can also be bifurcated at the end of the handle secured to the housing into two portions (722,724) such that there is a region between the two portions.
Patent CA-2670129-A1 (CA)
Title: In situ recovery from a hydrocarbon containing formation
Inventor: SCHOELING LANNY
IPC: E21B36/04
Filed: 2001-04-24
Abstract: A hydrocarbon containing formation may be treated using an in situ thermal process. A mixture of hydrocarbons, H2, and/or other formation fluids may be produced from the formation. Heat may be applied to the formation to raise a temperature of a portion of the formation to a pyrolysis temperature. The mixture produced from the formation may have a relatively high hydrogen partial pressure, and a large portion of the pressure within the formation may be attributable to hydrogen partial pressure.
Patent CA-2670316-A1 (CA)
Title: Port fixation with interlocking structure
Inventor: FISCHVOGT GREGORY
IPC: A61B17/34
Filed: 2009-06-26
Abstract: The present disclosure relates to a surgical access system that includes a cannula assembly adapted for removable positioning within a percutaneous tissue tract, and an obturator assembly removably positionable within the cannula assembly. The cannula assembly includes a cannula housing, a cannula sleeve, and first engagement structure, and the obturator assembly includes an obturator housing, an obturator sleeve, and second engagement structure. The first engagement structure and the second engagement structure are correspondingly dimensioned such that rotation of the obturator assembly in a first direction effectuates corresponding rotation of the cannula assembly to facilitate advancement of the cannula assembly through tissue.
Patent CA-2672536-A1 (CA)
Inventor: AIKATERINIDIS ANTONIOS
IPC: B65G63/00
Filed: 2007-11-29
Abstract: A method of inspecting a container during transfer of the container includes connecting a crane to the container by way of a spreader bar, causing a probe to engage an inspection port on the container, and probing the container. The probe may be an imaging probe, a camera, or another device for inspecting the contents of the container. The probe may be shielded, and the probe or shield may penetrate the inspection port with sufficient force to disengage a spring-loaded mount of a retractable port seal. The inspection port may be at a side wall of the container. Based on the findings of the probe, the container may be identified for further inspection. An apparatus for inspecting a container, a method of fitting a container for inspection, and an apparatus which may be fit to a container to facilitate inspection thereof are also disclosed.
Patent CA-2675424-A1 (CA)
Title: Polypropolyne compositions for the manufacture of microporous membranes
Inventor: OZAKI HIROYUKI
IPC: C08F10/06
Filed: 2008-01-17
Abstract: Disclosed herein is a polymer composition, its manufacture and use, said composition may comprise greater than about 90 mole % propylene monomer, and having a unique combination of properties, including one or more of the following: a heat of fusion of more than about 108 J/g, a melting point of 165°C or higher, a Melt Flow Rate so low that it is essentially not measurable and a molecular weight of greater than about 1.5 x 106. Further disclosed herein are blends or mixtures of the present novel polymer composition and products, such as, for example, microporous film structures and the like comprising same.
Patent CA-2676272-A1 (CA)
Inventor: VASCONI BERTRAND
IPC: E03B9/02
Filed: 2008-01-09
Abstract: The device has a control tube (4) provided with a male type maneuver end fitting at one end and a gate valve at another end, where the gate valve supplies water to a vertical conduit (3) from a main water supply system. An inlet (8) is connected on the conduit to receive fire extinction pipes. The inlet has a sealing knob (9) carrying a vane (15) cooperated with the control tube or with a wall of the conduit to prohibit the breaking of the knob in the inlet.
Patent CA-2676541-A1 (CA)
Inventor: REDMOND JERALD
IPC: A61F2/24
Filed: 2008-01-25
Abstract: Annuloplasty device for implantation adjacent an annulus of a tricuspid valve, the annulus comprising anterior, posterior and septal aspects adjacent anterior, posterior and septal leaflets, respectively, of the tricuspid valve, the device comprising: a ring body comprising: an anterior portion (50c), a posterior portion (50b) and a septal portion (50a) shaped to conform to, and for implantation adjacent, the anterior, posterior and septal aspects of the annulus, respectively; and first (51) and second (52) ends; wherein the ring body is curvilinear, with substantially no flat portions, forming a shape, and the ends are configured such that when the device is implanted, the first end will be located near the junction of the septal and anterior aspects of the annulus and the second end will be located near the septal aspect of the annulus. Related methods.
Patent CA-2677164-A1 (CA)
Title: Method and control system for processing greywater
Inventor: PLATTEEL JOHANNES DONAES JACOBUS
IPC: E03D5/00
Filed: 2008-02-06
Abstract: The present invention relates to a method for processing greywater, comprising the following steps: - supplying water to a reservoir of a greywater device; - collecting the supplied water in the reservoir; - conducting water out of the reservoir to at least one reservoir of a water consumer; - monitoring the water quality; and - flushing the water from the reservoir of the greywater device and/or the reservoir of the water consumer into a sewer drain when the water quality drops below an acceptable level. Furthermore, the invention relates to a control system for controlling a greywater device, a system for reusing greywater, comprising a greywater device and a control system, and a greywater consumer, in particular a toilet, which is connected to such a system.
Patent CA-2677170-A1 (CA)
Inventor: LEYS CARINA
IPC: C07D417/04
Filed: 2008-02-01
Abstract: Provided are crystalline forms of the compound of formula (I), which is a macrocyclic inhibitor of HCV, processes for the preparation thereof, and pharmaceutical compositions comprising these crystalline forms.
Patent CA-2681909-A1 (CA)
Title: Device and method for controlling the water temperature on at least one water outlet
Inventor: KURES GERALD
IPC: C02F1/02
Filed: 2008-03-20
Abstract: The invention relates to a device and a method for controlling the water temperature on at least one water outlet of a water line comprising a safety mixing valve having a warm water inlet and a cold water inlet, with which a predetermined temperature of the mixed water coming from the water line can be set and with which water flow is prevented if the predetermined water temperature is exceeded. A bypass line having a valve is associated with the safety mixing valve such that, if the valve is in an open position, the warm water is guided to the water outlet by bypassing the safety mixing valve.
Patent CA-2682922-A1 (CA)
Title: Fungicide mixtures
Inventor: WERNER FRANK
IPC: A01P3/00
Filed: 2008-04-07
Abstract: The invention relates to fungicide mixtures containing, as active constituents: 1) metconazole of formula (I), and 2) prochloraz of formula (II), in synergistically effective quantities, and to means containing said mixtures.
Patent CA-2683860-A1 (CA)
Title: Device and method for detecting and counting articles, released by a feeder device, in particular sheet articles released by a sheet feeder
Inventor: ORFEI FRANCESCO
IPC: B65B57/20
Filed: 2008-04-14
Abstract: A method and device for detecting and counting articles released by a feeder device, in particular sheet articles released by a sheet feeder are described. The device comprises: an electromagnetic resonator (11 ) fed by a signal generator (12), to generate an electromagnetic field in a passage region (9) of said sheet articles (3); a sensor (13) connected to the electromagnetic resonator (11 ) for detecting the induced disturbances in the electromagnetic field following the passage of one or more superimposed sheet articles (3); and a control unit (14) connected to the sensor (13) for calculating the number of sheet articles (3), which pass from time to time across the passage region (9). In particular, the electromagnetic resonator (11) is of recess type and in it an aperture (7) is made which makes said recess (8) communicating with the outside; whereby the resonator (11 ) is arranged so that the aperture (7) is disposed at the passage region (9).
Patent CA-2685168-A1 (CA)
Inventor: WUSSLER RENE
IPC: G06F3/033
Filed: 2009-11-09
Abstract: The present invention relates to an input device having at least one mechanical control element which may be used for controlling the setting of a parameter. The invention further relates to a method of detecting a user input with an input device. An input event can be detected in response to an actuation of a mechanical control element and a parameter may be adjusted in accordance with the detected input event. Further, an audio console comprising an input device is provided.
Patent CA-2685563-A1 (CA)
Inventor: GODEK CHRISTOPHER P
IPC: A61B18/04
Filed: 2008-04-30
Abstract: Target tissue may be removed from a subject using a cannula that has an interior cavity and an orifice configured to permit material to enter the cavity. This is accomplished by generating a negative pressure in the cavity so that a portion of the tissue is drawn into the orifice. Fluid is then delivered, via a conduit, so that the fluid exits the conduit within the cavity and impinges against the portion of the tissue that was drawn into the orifice. The fluid is delivered at a pressure and temperature that causes the tissue to soften, liquefy, or gellify. The tissue that has been softened, liquefied, or gellified is then suctioned away.
Patent CA-2685638-A1 (CA)
Inventor: SILVESTRE LOUISE
IPC: A61K38/26
Filed: 2009-11-13
Abstract: A method for the treatment of diabetes mellitus type 2 comprising administering (d) desPro36Exendin-4(1-39)-Lys6-NH2 or/and a pharmaceutically acceptable salt thereof, (e) insulin glargine or/and a pharmaceutically acceptable salt thereof, and (f) metformin or/and a pharmaceutically acceptable salt thereof, to a subject in need thereof.
Patent CA-2685699-A1 (CA)
Title: Method of manufacturing a z-section component from composite material
Inventor: LAURIOLA MATTEO
IPC: B29C70/44
Filed: 2008-04-30
Abstract: What is described is a method of manufacturing a Z -section component from composite material, using a mould (12) having a convex mould portion (12a)' and a concave mould portion (12b). The method includes the preparation of a vacuum bag (90) for a polymerization cycle, comprising the following stages: covering the fresh component' with a layer of peel ply (60) formed from a plurality of strips of peel ply (61a, 61b, 61c); fixing the layer of peel ply perimetrically to the mould, using an adhesive tape (65); positioning a line of sealant (66) perimetrically above 'the adhesive tape around the fresh component; positioning a separator film (70) above the layer of peel ply so as to cover the layer of peel ply and the perimetric line of sealant; positioning a ventilation textile (80) perimetrically on the mould (12), this textile having an aperture (81) which is positioned so as to leave uncovered an underlying part substantially coinciding with the fresh component; and applying the vacuum bag for the polymerization cycle. The method includes also a preliminary compaction of successively deposited layers of preimpregnated material.
Patent CA-2686581-A1 (CA)
Inventor: VON ROTZ ANDRE
IPC: B01F25/46
Filed: 2009-12-02
Abstract: An intermediate piece (4) for the connection of a static mixer (1) to a dispensing cartridge or to a dispensing device for a plurality of components contains a first passage (30) for a first component and a second passage (40) for a second component, wherein the first passage (30) runs through the intermediate piece separate from the second passage (40). A first inlet opening (31) is provided which opens into the first passage (30), and a second inlet opening (41) is provided which opens into the second passage (40), wherein the first inlet opening (31) includes an element (16, 60) so that the first inlet opening (31) can be aligned by means of the element (16, 60) in a matching position to the dispensing cartridge or to the dispensing device.
Patent CA-2695584-A1 (CA)
Inventor: DRAKE DANIEL VERNON
IPC: B66F5/02
Filed: 2010-03-04
Abstract: Various embodiments of a vehicle jack include an elevation assembly and a guide bracket. The elevation assembly includes a threaded member and an elongated support member, with the elongated support member configured to threadedly engage and rotate relative to the threaded member. The guide assembly includes a guide bracket configured to engage the threaded member such that the threaded member moves with the guide assembly as the guide assembly moves along a path defined by a longitudinal axis of the elongated support member.  This movement raises or lowers a vehicle positioned on the jack. Various embodiments address the assembly of a vehicle jack by engaging a threaded member with an elongated support member and a guide bracket. Rotation of the elongated support member about its longitudinal axis causes the threaded member to move the guide bracket along a path defined by the longitudinal axis.
Patent CA-2696597-A1 (CA)
Title: Foxm1 peptide and medicinal agent comprising the same
Inventor: NISHIMURA YASUHARU
IPC: A61P35/00
Filed: 2008-08-12
Abstract: An objective of the present invention is to provide a means for enabling cancer immunotherapy that targets approximately 30% of various cancer patients that highly express forkhead box M1 (FOXM1) among the Japanese, by identifying FOXM1-derived peptides that can activate cancer cell-damaging human killer T  cells by binding to HLA-A2. The present invention provides a peptide of (A) or (B) below: (A) a peptide including the amino acid sequence of any one of SEQ ID NOs: 1 to 3; (B) a peptide which includes the amino acid sequence of any one of SEQ ID  NOs: 1 to 3, wherein one, two, or several amino acid(s) are substituted, deleted, inserted, and/or added, and wherein the peptide shows cytotoxic (killer) T  cell-inducing activity.
Patent CA-2696782-A1 (CA)
Inventor: RAMBOW FREDERICK HENRY KREISLER
IPC: G01D5/353
Filed: 2008-09-04
Abstract: A system and a method that are useful for making temperature measurements that are distributed over a distance. In one aspect, the system comprises a plurality of Bragg grating measurement points disposed in an optical fiber with a predetermined spacing between adjacent Bragg grating measurement points. The system also comprises a substrate with the optical fiber disposed thereon, the optical fiber wrapped around the substrate with at least one predetermined wrap angle. The predetermined wrap angle and the predetermined spacing may be selected to allow a temperature measurement signal to be distinguished from a bending measurement signal. The substrate may have a first coefficient of thermal expansion greater than a second coefficient of thermal expansion of the optical fiber and may comprise alternating sections of hollow tube and solid rod.
Patent CA-2696799-A1 (CA)
Inventor: KAKEFUDA AKIO
IPC: A61P13/08
Filed: 2008-08-28
Abstract: As a result of studies on compounds having a selective inhibitory activity against 17.beta.HSD type 5, the present inventors have confirmed that a {1-[(indol-2--yl) carbonyl]piperidyl}alkanol derivative has a potent selective inhibitory activity against 17.beta.HSD type 5. The invention has been completed based on these findings.  The compound of the present invention can be used as an agent for treating and/or an agent for preventing diseases associated with 17.beta.HSD type 5, such as benign prostatic hyperplasia and prostate cancer, without accompanying adverse effects due to a decrease in testosterone.
Patent CA-2696832-A1 (CA)
Inventor: HAYASHI TOMOKAZU
IPC: H01M8/04
Filed: 2009-08-27
Abstract: To reduce gas pressure loss in a gas flow passage of a fuel cell as required, the fuel cell has a cell structure in which a gas flow passage is formed by an expanded metal, a bond portion (BO) connecting a mesh of the expanded metal (28) stands partially upright in a position where a bond length is shortened so as to form a part of a strand portion (ST). Hence, in an opening (30) formed by the mesh of the expanded metal (28), a surface area on which front and rear openings (30) overlap in a (TD) direction increases when seen from an (FD) direction. Thus, a sectional area of gas flow passages constituted by a continuum in the (FD) direction of the openings (30) overlapping in the (TD) direction increases. As a result, a gas flow (GF) flows without making repeated narrow turns, reducing gas pressure loss.
Patent CA-2698561-A1 (CA)
Title: Hyaluronic acid oligosaccharide fractions and drugs containing the same
Inventor: ASARI AKIRA
IPC: A61P43/00
Filed: 2001-07-06
Abstract: Hyaluronic acid oligosaccharides having a size selected from sizes of 4 to 60 saccharides, fractions containing the hyaluronic acid oligosaccharides and having particular physicochemical properties, and drugs containing the same. The hyaluronic acid oligosaccharides of the present invention are extremely useful, because they exert superior pharmaceutical effects as active ingredients of a heat shock protein expression promoter, cell death inhibitor, cell injury inhibitor and cell and tissue protecting agent (e.g., organ preservation agent, antiulcer agent, antihepatopathic agent, IL-10 production promoter or IL-8 production inhibitor) and exhibit high safety. <IMAGE>
Patent CA-2699528-A1 (CA)
Inventor: KIMURA NAOKO
IPC: A61F2/28
Filed: 2008-09-02
Abstract: The direction of pores in an artificial bone can be easily and accurately known. An artificial bone 10 has substantially unidirectionally-oriented pores 2 in the inside of an artificial bone material (artificial bone main body) 1 and has, on its surface, a marker, for example, line symbol 3a, showing the orientation direction of the substantially unidirectionally-oriented pores 2. The marker may be a protrusion, a pit etc. besides line symbol 3a. As a result, the direction of substantially unidirectionally-oriented pores in an artificial bone can be confirmed easily.
Patent CA-2701713-A1 (CA)
Inventor: TROOSTWYK JOHN ALEXANDER
IPC: C07J5/00
Filed: 2008-09-30
Abstract: The present invention relates to hydrocortisone derivatives, the method of production thereof and the therapeutic or cosmetic use thereof to combat hair loss or in the treatment of cutaneous physiopathologies.
Patent CA-2701956-A1 (CA)
Title: Combination therapy
Inventor: THIBERT ROCH
IPC: A61P11/06
Filed: 2008-10-23
Abstract: The present invention provides inhalation compositions comprising montelukast acid and a second active agent selected from a PDE4 inhibitor and an inhaled corticosteroid. Also provided is a method for the treatment of respiratory disorders such as asthma using such compositions.
Patent CA-2705481-A1 (CA)
Inventor: FANG WEISHUO
IPC: C07D305/14
Filed: 2007-11-15
Abstract: Cephalomannine derivatives of formula(I),their preparation, the composition including them, and their use of manufacturing of anti-tumor medicaments, especially of the medicaments against multidrug resistant tumor.
Patent CA-2705682-A1 (CA)
Inventor: LIST BENJAMIN
IPC: C07D251/48
Filed: 2008-11-12
Abstract: A process for the synthesis of 3,6-dihydro-1,3,5-triazine derivatives is claimed wherein a biguanid is reacted with acetaldehyde in the presence of an inorganic and/or organic base.  The process can be carried out at mild and therefore economical reaction conditions.
Patent CA-2707350-A1 (CA)
Inventor: GUDMUNDSSON JULIUS
IPC: G16H70/60
Filed: 2008-12-05
Abstract: It has been discovered that certain polymorphic markers on chromosome 6 and chromosome 11 are indicative of a susceptibility to prostate cancer and colon cancer. The invention describes diagnostic applications for determining a susceptibilty to cancer using such markers, as well as kits for use in such applications.
Patent CA-2708176-A1 (CA)
Inventor: PRICE STEPHEN
IPC: C07D487/04
Filed: 2008-12-19
Abstract: The invention relates to azaindolizines of formula I-a or I-b with anti-cancer and/or anti-inflammatory activity and more specifically to azaindolizines which inhibit MEK kinase activity. The invention provides compositions and methods useful for inhibiting abnormal cell growth or treating a hyperproliferative disorder, or treating an inflammatory disease in a mammal. The invention also relates to methods of using the compounds for in vitro,in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
Patent CA-2710465-A1 (CA)
Inventor: ZHAO LIANG
IPC: G01S19/46
Filed: 2008-12-18
Abstract: The subject matter disclosed herein relates to a system and method for processing navigation signals received from multiple global navigation satellite systems (GNSS'). In a particular implementation, signals received from multiple GNSS' may be processed in a single receiver channel.
Patent CA-2711818-A1 (CA)
Title: Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening
Inventor: TANGUAY JEAN-FRANCOIS
IPC: A61K31/337
Filed: 2008-09-22
Abstract: A method of using an estrogen receptor agonist and antagonist to reduce a toxic effect of a cytostatic drug on bone marrow derived cells in a biological system. The methods comprise contacting the cells with a therapeutically effective amount of an estrogen receptor agonist or antagonist, and contacting the cells with a cytostatic agent, whereby the toxic effect of the cytostatic drug on bone marrow derived cells is reduced. Agonists disclosed include 17-beta-estradiol. Antagonists disclosed include antisense nucleic acids and selective estrogen receptor modulators (SERMs). Furthermore, uses and medicaments comprising estrogen receptor agonists and antagonists are provided, as are screening methods for identifying therapeutic candidates for reducing the effect of cytostatic agents, and methods of using estrogen receptor agonists for increasing the proliferation of CD117+ cells in a biological system.